Published in J Biol Chem on October 16, 2003
Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res (2009) 1.87
Viral determinants of resistance to treatment in patients with hepatitis C. Clin Microbiol Rev (2007) 1.65
The hantavirus nucleocapsid protein recognizes specific features of the viral RNA panhandle and is altered in conformation upon RNA binding. J Virol (2005) 1.30
Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus. J Biol Chem (2009) 1.17
Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance. J Virol (2009) 1.07
Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob Agents Chemother (2012) 0.95
Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-α. PLoS One (2012) 0.94
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis. PLoS One (2013) 0.81
Characterization of the DNA- and dNTP-binding activities of the human cytomegalovirus DNA polymerase catalytic subunit UL54. Biochem J (2007) 0.81
Ribosomal protein S19-binding domain provides insights into hantavirus nucleocapsid protein-mediated translation initiation mechanism. Biochem J (2014) 0.81
Replicative homeostasis III: implications for antiviral therapy and mechanisms of response and non-response. Virol J (2007) 0.79
Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production. PLoS One (2015) 0.78
Host-based ribavirin resistance influences hepatitis C virus replication and treatment response. J Virol (2011) 0.78
Affinity labeling of hepatitis C virus replicase with a nucleotide analogue: identification of binding site. Biochemistry (2013) 0.77
Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/Sofosbuvir. Clin Infect Dis (2016) 0.76
Ribavirin suppresses bacterial virulence by targeting LysR-type transcriptional regulators. Sci Rep (2016) 0.75
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir. PLoS One (2016) 0.75
The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure. RNA (2009) 1.58
Developing three-dimensional models of putative-folding intermediates of the HDV ribozyme. Structure (2010) 1.49
Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus. J Biol Chem (2005) 1.17
The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme. J Biol Chem (2004) 1.15
Characterization of the metal ion binding properties of the hepatitis C virus RNA polymerase. J Biol Chem (2002) 0.98
Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells. J Hepatol (2007) 0.97
Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap. RNA (2005) 0.90
Identification of proteins from prunus persica that interact with peach latent mosaic viroid. J Virol (2009) 0.90
Monitoring of an RNA multistep folding pathway by isothermal titration calorimetry. Biophys J (2009) 0.89
Inhibition of a metal-dependent viral RNA triphosphatase by decavanadate. Biochem J (2006) 0.87
The RNA strands of the plus and minus polarities of peach latent mosaic viroid fold into different structures. RNA (2010) 0.86
Mapping studies of the Peach latent mosaic viroid reveal novel structural features. Mol Plant Pathol (2011) 0.86
Examination of the folding pathway of the antigenomic hepatitis delta virus ribozyme reveals key interactions of the L3 loop. RNA (2006) 0.84
Elements in the canine distemper virus M 3' UTR contribute to control of replication efficiency and virulence. PLoS One (2012) 0.84
Effect of metal ion binding on the structural stability of the hepatitis C virus RNA polymerase. J Biol Chem (2004) 0.83
Energetics of RNA binding by the West Nile virus RNA triphosphatase. FEBS Lett (2006) 0.83
Kinetic and thermodynamic characterization of the RNA guanylyltransferase reaction. Biochemistry (2008) 0.82
Metal ion-binding studies highlight important differences between flaviviral RNA polymerases. Biochim Biophys Acta (2008) 0.82
Characterization of the DNA- and dNTP-binding activities of the human cytomegalovirus DNA polymerase catalytic subunit UL54. Biochem J (2007) 0.81
The RNA capping machinery as an anti-infective target. Wiley Interdiscip Rev RNA (2010) 0.81
Thermodynamics of ligand binding by the yeast mRNA-capping enzyme reveals different modes of binding. Biochem J (2004) 0.80
Programming a highly structured ribozyme into complex allostery using RNA oligonucleotides. ACS Chem Biol (2012) 0.79
Magnesium-binding studies reveal fundamental differences between closely related RNA triphosphatases. Nucleic Acids Res (2007) 0.79
Enzymatic synthesis of RNAs capped with nucleotide analogues reveals the molecular basis for substrate selectivity of RNA capping enzyme: impacts on RNA metabolism. PLoS One (2013) 0.79
Insights into the molecular determinants involved in cap recognition by the vaccinia virus D10 decapping enzyme. Nucleic Acids Res (2010) 0.79
Nucleotide analogs and molecular modeling studies reveal key interactions involved in substrate recognition by the yeast RNA triphosphatase. Nucleic Acids Res (2009) 0.79
Deciphering the molecular basis for nucleotide selection by the West Nile virus RNA helicase. Nucleic Acids Res (2010) 0.79
Characterization of the vaccinia virus D10 decapping enzyme provides evidence for a two-metal-ion mechanism. Biochem J (2009) 0.78
A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease. PLoS One (2011) 0.78
Characterization of the RNA binding energetics of the Candida albicans poly(A) polymerase. Yeast (2007) 0.77
Analysis of decapping scavenger cap complex using modified cap analogs reveals molecular determinants for efficient cap binding. FEBS J (2013) 0.76
Virtual high-throughput screening identifies mycophenolic acid as a novel RNA capping inhibitor. PLoS One (2011) 0.75
The immunosuppressive agent mizoribine monophosphate is an inhibitor of the human RNA capping enzyme. PLoS One (2013) 0.75
[Synergy between transcription and mRNA processing events]. Med Sci (Paris) (2006) 0.75
Further characterization and determination of the single amino acid change in the tsI138 reovirus thermosensitive mutant. Can J Microbiol (2012) 0.75